Bailard Inc. boosted its place in shares of Agilent Applied sciences, Inc. (NYSE:A – Free Report) by 4.4% in the course of the second quarter, Holdings Channel.com studies. The agency owned 2,613 shares of the medical analysis firm’s inventory after shopping for an extra 111 shares in the course of the quarter. Bailard Inc.’s holdings in Agilent Applied sciences have been value $339,000 on the finish of the newest quarter.
A number of different institutional traders and hedge funds additionally just lately purchased and offered shares of the corporate. Quantbot Applied sciences LP bought a brand new place in Agilent Applied sciences in the course of the first quarter value about $938,000. Cetera Funding Advisers elevated its holdings in Agilent Applied sciences by 953.3% within the 1st quarter. Cetera Funding Advisers now owns 32,694 shares of the medical analysis firm’s inventory valued at $4,757,000 after buying an extra 29,590 shares over the past quarter. UBS Group AG raised its place in Agilent Applied sciences by 84.5% within the fourth quarter. UBS Group AG now owns 325,695 shares of the medical analysis firm’s inventory valued at $45,281,000 after buying an extra 149,159 shares in the course of the interval. TD Asset Administration Inc raised its place in Agilent Applied sciences by 27.1% within the fourth quarter. TD Asset Administration Inc now owns 1,609,420 shares of the medical analysis firm’s inventory valued at $223,758,000 after buying an extra 343,175 shares in the course of the interval. Lastly, iA International Asset Administration Inc. lifted its stake in Agilent Applied sciences by 26.2% in the course of the first quarter. iA International Asset Administration Inc. now owns 21,770 shares of the medical analysis firm’s inventory value $3,168,000 after buying an extra 4,523 shares within the final quarter. 87.42% of the inventory is presently owned by institutional traders and hedge funds.
Agilent Applied sciences Buying and selling Down 0.3 %
Shares of Agilent Applied sciences inventory opened at $140.50 on Tuesday. The corporate’s fifty day shifting common is $134.34 and its two-hundred day shifting common is $138.65. Agilent Applied sciences, Inc. has a 1 12 months low of $96.80 and a 1 12 months excessive of $155.35. The corporate has a debt-to-equity ratio of 0.34, a fast ratio of 1.64 and a present ratio of two.15. The corporate has a market capitalization of $40.99 billion, a P/E ratio of 33.22, a PEG ratio of 4.86 and a beta of 1.05.
Agilent Applied sciences (NYSE:A – Get Free Report) final issued its quarterly earnings outcomes on Wednesday, August twenty first. The medical analysis firm reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.06. Agilent Applied sciences had a return on fairness of 26.25% and a internet margin of 18.84%. The agency had income of $1.58 billion for the quarter, in comparison with analysts’ expectations of $1.56 billion. Throughout the identical quarter within the earlier 12 months, the agency posted $1.43 EPS. The agency’s income for the quarter was down 5.6% on a year-over-year foundation. Analysts forecast that Agilent Applied sciences, Inc. will put up 5.24 earnings per share for the present 12 months.
Insider Transactions at Agilent Applied sciences
In different Agilent Applied sciences information, CEO Padraig Mcdonnell offered 1,958 shares of the corporate’s inventory in a transaction on Monday, June third. The shares have been offered at a median value of $130.00, for a complete transaction of $254,540.00. Following the completion of the transaction, the chief govt officer now owns 25,185 shares within the firm, valued at roughly $3,274,050. The sale was disclosed in a authorized submitting with the SEC, which may be accessed via this hyperlink. In associated information, SVP Dominique Grau offered 15,000 shares of Agilent Applied sciences inventory in a transaction that occurred on Monday, June tenth. The inventory was offered at a median value of $133.28, for a complete worth of $1,999,200.00. Following the sale, the senior vp now straight owns 49,486 shares within the firm, valued at $6,595,494.08. The transaction was disclosed in a doc filed with the SEC, which may be accessed via this hyperlink. Additionally, CEO Padraig Mcdonnell offered 1,958 shares of the inventory in a transaction on Monday, June third. The inventory was offered at a median value of $130.00, for a complete worth of $254,540.00. Following the completion of the transaction, the chief govt officer now owns 25,185 shares of the corporate’s inventory, valued at roughly $3,274,050. The disclosure for this sale may be discovered right here. Insiders offered 20,874 shares of firm inventory value $2,811,770 during the last 90 days. 0.33% of the inventory is presently owned by insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on the corporate. Evercore ISI lifted their goal value on Agilent Applied sciences from $130.00 to $135.00 and gave the corporate an “in-line” score in a analysis report on Thursday, August twenty second. Citigroup raised their goal value on shares of Agilent Applied sciences from $150.00 to $165.00 and gave the corporate a “purchase” score in a report on Thursday, August twenty second. UBS Group boosted their goal value on shares of Agilent Applied sciences from $141.00 to $150.00 and gave the inventory a “impartial” score in a analysis word on Thursday, August twenty second. Stifel Nicolaus reissued a “purchase” score and set a $151.00 goal value on shares of Agilent Applied sciences in a analysis report on Monday. Lastly, Jefferies Monetary Group reissued a “maintain” score and set a $135.00 value goal (down beforehand from $152.00) on shares of Agilent Applied sciences in a report on Monday, June third. One analysis analyst has rated the inventory with a promote score, six have assigned a maintain score and 9 have issued a purchase score to the corporate. Based on MarketBeat.com, the inventory presently has a consensus score of “Reasonable Purchase” and a consensus value goal of $140.80.
Get Our Newest Analysis Report on Agilent Applied sciences
Agilent Applied sciences Profile
Agilent Applied sciences, Inc supplies utility targeted options to the life sciences, diagnostics, and utilized chemical markets worldwide. The corporate operates in three segments: Life Sciences and Utilized Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Utilized Markets phase gives liquid chromatography programs and elements; liquid chromatography mass spectrometry programs; fuel chromatography programs and elements; fuel chromatography mass spectrometry programs; inductively coupled plasma mass spectrometry devices; atomic absorption devices; microwave plasma-atomic emission spectrometry devices; inductively coupled plasma optical emission spectrometry devices; raman spectroscopy; cell evaluation plate based mostly assays; stream cytometer; real-time cell analyzer; cell imaging programs; microplate reader; laboratory software program; data administration and analytics; laboratory automation and robotic programs; dissolution testing; and vacuum pumps, and measurement applied sciences.
Learn Extra
Need to see what different hedge funds are holding A? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Agilent Applied sciences, Inc. (NYSE:A – Free Report).
Obtain Information & Rankings for Agilent Applied sciences Each day – Enter your e mail handle beneath to obtain a concise day by day abstract of the newest information and analysts’ rankings for Agilent Applied sciences and associated firms with MarketBeat.com’s FREE day by day e mail publication.
